NVCT

Nuvectis Pharma, Inc.

9.91 USD
+0.14 (+1.43%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Nuvectis Pharma, Inc. stock is up 34.28% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 2 February’s closed higher than January.

About Nuvectis Pharma, Inc.

Nuvectis Pharma focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.